LAUSR

Background: Almost a year to the pandemic situation gone, but still no approved scientific treatment only experimental cocktail for novel coronavirus disease. Ayurveda as a complementary medicine, claims the Ayurveda drug has strong immunity boosting and anti-inflammatory benefits against the coronavirus. To get a global recognition, AYUSH system encourages to carry a randomized controlled clinical trial to treat novel coronavirus disease. In this study, we aimed to summarize the effectiveness of Ayurveda interventions and which interventions are most effective in management of COVID19 positive patients. Methods: To ensure relative efficacy of Ayurveda interventions in management of COVID 19 positive patients, we will systematically search randomized controlled trials and quasi-randomised controlled trials in electronic databases. Also, we will search unpublish material from pre-print servers and grey literature. Two independent researchers will conduct the selection process based on inclusion and exclusion criteria according to PRISMA guidelines. Upon selection, we will carry out quality assessment with the help of GRADE and risk of bias assessment using Cochrane Collaboration’s Risk of Bias Assessment Tool. Using R-3.4.1 software to process and analyse data. Result: The results of this study will be published in a peer-reviewed journal. Discussion: The findings from this study will provide directions for further research and provide helpful evidence for clinicians to formulate best Ayurveda treatment strategy for management of COVID-19 positive patients. Systematic review registration: International Prospective Register for Systematic Reviews (PROSPERO) number CRD42021267410.